Skip to content
Study details
Enrolling now

Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation

University of New Mexico
NCT IDNCT06940609ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

60

Study length

about 4 years

Ages

18–80

Locations

1 site in NM

What this study is about

This trial is testing whether a type of rapid outpatient brain stimulation that uses magnetic fields, called accelerated intermittent theta burst stimulation (iTBS), can treat symptoms such as brain fog, depression, and anxiety in patients with Long COVID. The main questions it aims to answer are: Is iTBS effective and feasible for reducing Long COVID symptoms? We will measure these symptoms using the Symptom Burden Questionnaire. Are there changes in inflammatory brain chemicals associated with treatment with iTBS? We will be looking at levels of choline in the brain, which is thought to be related to inflammation.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use accelerated intermittent theta burst stimulation

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Devices

therapeutic

Body systems

Infectious